Trial Profile
A Follow-up Study to Examine the Presence of Anti-human Growth Hormone Antibodies Following a Randomised, Open-label, Parallel-group, Multi-centre Trial (FE 999905 CS07) in Which the Efficacy and Safety of 12 Months' Treatment With One Daily Dose of ZOMACTON Were Compared to One Daily Dose of GENOTROPIN
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Somatropin (Primary)
- Indications Somatotropin deficiency
- Focus Pharmacodynamics
- Sponsors Ferring Pharmaceuticals
- 04 May 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 05 Jul 2014 New source identified and integrated (European Clinical Trials Database record: EudraCT2014-000627-24HU)
- 01 Jul 2014 New trial record